UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000033944
Receipt No. R000038711
Official scientific title of the study Study on the plasma adenosine mobilization in patients with acute myocardial infarction.
Date of disclosure of the study information 2020/04/01
Last modified on 2018/08/29 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study on the plasma adenosine mobilization in patients with acute myocardial infarction.
Title of the study (Brief title) ADENOSINE-AMI
Region
Japan

Condition
Condition acute myocardial infarction
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Investigate the relationship between mobilized adenosine and left ventricular remodeling in patients with acute myocardial infarction.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The number of mobilized adenosine concentration and effect on 6 months later left ventricular remodeling in patients with acute myocardial infarction.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with acute myocardial infarction.

Patients with significant coronary artery stenosis .

Patients without significant coronary stenosis.
Key exclusion criteria Patients whom the doctor decided not to include because of various reasons.
Target sample size 100

Research contact person
Name of lead principal investigator Toshiki Tanaka
Organization Gifu University
Division name Department of Cardiology
Address Yanagido 1-1, Gifu, Gifu
TEL 058-230-6520
Email toshizo@gifu-u.ac.jp

Public contact
Name of contact person Toshiki Tanaka
Organization Gifu University
Division name Department of Cardiology
Address Yanagido 1-1, Gifu, Gifu
TEL 058-230-6520
Homepage URL
Email toshizo@gifu-u.ac.jp

Sponsor
Institute Department of Cardiology, Gifu University Graduate School of Medicine
Institute
Department

Funding Source
Organization Department of Cardiology, Gifu University Graduate School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor Japanese Red Cross Takayama Hospital
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 04 Month 01 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2016 Year 01 Month 06 Day
Anticipated trial start date
2016 Year 01 Month 06 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Patients who were admitted to Gifu University Hospital & Japanese Red Cross Takayama Hospital were included in this study. Diagnosis of AMI was defined based on the presence of prolonged anterior chest pain, ST segment elevation in electrocardiogram, and an occluded coronary artery by coronary angiography. AMI patients were treated with percutaneous coronary intervention followed by standard pharmacological treatment, such as anti-platelet therapy.

Management information
Registered date
2018 Year 08 Month 29 Day
Last modified on
2018 Year 08 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038711